EcoDrugPlus

Adrenoceptor Alpha 2c

Ensembl ID : ENSDCDG00000027977
Gene Symbol: ADRA2C
1 Cross references
161 Possible Orthologues:

Adrenoceptor Beta 1

Ensembl ID : ENSDCDG00000003554
Gene Symbol: ADRB1
3 Cross references
163 Possible Orthologues:

Adrenoceptor Beta 3b

Ensembl ID : ENSDCDG00000023766
Gene Symbol: ADRB3B
1 Cross references
146 Possible Orthologues:

Aldo-Keto Reductase Family 1 Member B1-Like

Ensembl ID : ENSDCDG00000021999
Gene Symbol: LOC114764615
3 Cross references
348 Possible Orthologues:

Aldo-Keto Reductase Family 1 Member B1-Like

Ensembl ID : ENSDCDG00000022070
Gene Symbol: LOC114764655
3 Cross references
350 Possible Orthologues:

Alpha-1a Adrenergic Receptor-Like

Ensembl ID : ENSDCDG00000033364
Gene Symbol: LOC114799940
3 Cross references
202 Possible Orthologues:

Alpha-2b Adrenergic Receptor-Like

Ensembl ID : ENSDCDG00000030976
Gene Symbol: LOC114786987
2 Cross references
116 Possible Orthologues:

Alpha-Synuclein-Like

Ensembl ID : ENSDCDG00000016145
Gene Symbol: LOC114786771
2 Cross references
189 Possible Orthologues:

Amine Oxidase Copper Containing 1

Ensembl ID : ENSDCDG00000028146
Gene Symbol: AOC1
3 Cross references
233 Possible Orthologues:

Amyloid Beta Precursor Protein

Ensembl ID : ENSDCDG00000002808
Gene Symbol: APP
3 Cross references
206 Possible Orthologues:

Amyloid-Beta A4 Protein-Like

Ensembl ID : ENSDCDG00000014326
Gene Symbol: LOC114796380
3 Cross references
205 Possible Orthologues:

Androgen Receptor

Ensembl ID : ENSDCDG00000019212
Gene Symbol: AR
3 Cross references
214 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).